✦ LIBER ✦

Antisense Oligonucleotides for Therapeutic Interventions in Neuromuscular Diseases

✍ Scribed by Danos, Olivier

Book ID: 120985214
Publisher: Mary Ann Liebert
Year: 2013
Tongue: English
Weight: 52 KB
Volume: 24
Category: Article
ISSN: 1043-0342
DOI: 10.1089/hum.2013.2504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antisense oligonucleotides for therapeut

Antisense oligonucleotides for therapeutic intervention

✍ Stephen L. Eck; Gary J. Nabel 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Antisense oligonucleotides for therapeut

Antisense oligonucleotides for therapeutic intervention

✍ Stephen L. Eck; Gary J. Nabel 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 801 KB

Advances have been made in defining the best target sequences for use in antisense oligonucleotide technology, and new chemical derivatives of oligonucleotides are being investigated. Although the potential use of antisense oligonucleotide agents in the treatment of neoplastic, viral and parasitic d

Antisense oligonucleotide-based therapeu

Antisense oligonucleotide-based therapeutics for cancer

✍ Dean, Nicholas M; Bennett, C Frank 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 176 KB

P18 Developing allele-selective silencin

P18 Developing allele-selective silencing by antisense oligonucleotide as a therapeutic strategy for autosomal dominant neuromuscular diseases

✍ Zhou, H.; Muntoni, F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Progress in therapeutic antisense applic

Progress in therapeutic antisense applications for neuromuscular disorders

✍ Aartsma-Rus, Annemieke; van Ommen, Gert-Jan B 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 510 KB

Therapeutic options for neuromuscular di

Therapeutic options for neuromuscular diseases

✍ Marc Kent 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 315 KB